← Open Payments lookup

CHARLOTTE LINDSEY: Open Payments

NPI 1326204405 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$296 in 13 payments from 9 companies in 2025. Trend: 2023 $127 · 2024 $198 · 2025 $296

Food & beverage: $296
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$67
Janssen Pharmaceuticals, Inc2$58
E.R. Squibb & Sons, L.L.C.2$44
Teva Pharmaceuticals USA, Inc.1$35
ABBVIE INC.1$22
Lundbeck LLC1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Otsuka America Pharmaceutical, Inc.1$17
Alkermes, Inc.1$15

Products named: INGREZZA, INVEGA SUSTENNA, COBENFY, REXULTI, AUSTEDO XR, VRAYLAR, CAPLYTA, ARISTADA.

Industry payments across TX — which companies pay providers there.